Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB00669_nanopub.RAnBTVr_pp3Eez4AGEg3JsRBJdSlIajmOJvMi_GOP-UM8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB00669 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00669 label "DDI between Zolmitriptan and Sumatriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and sumatriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated. [drugbank_resource:DB00315_DB00669]" assertion.
- drugbank_resource:DB00315_DB00669 identifier "drugbank_resource:DB00315_DB00669" assertion.
- drugbank_resource:DB00315_DB00669 title "DDI between Zolmitriptan and Sumatriptan - Concomitant use of two serotonin 5-HT1D receptor agonists, such as zolmitriptan and sumatriptan, may result in additive vasoconstrictive effects. Concomitant use within 24 hours is contraindicated." assertion.
- drugbank:DB00669 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00669 assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00669 assertion.